Abstract:Objective:To investigate the efficacy and prognosis of three surgical methods for presacral recurrent rectal cancer (PRRC).Methods:A retrospective cohort study was carried out. Case inclusion criteria: (1) primary rectal cancer without distant metastasis and undergoing radical surgery; (2) patients undergoing radical surgery after the diagnosis of PRRC; (3) complete inpatient, outpatient and follow-up data. Clinical data of 47 patients meeting the above criteria who underwent operation at the Department of Gastrointestinal Surgery, The Peking University People's Hospital from January 2008 to December 2017 were reviewed and analyzed retrospectively. Of the 47 patients, 31 were male and 16 were female; the mean age was 57 years old; 9 (19.1%) were low differentiation or signet ring cell carcinoma, 38 (80.9%) were medium differentiation; 19 (40.4%) received neoadjuvant therapy. According to operative procedure, 22 patients were in the abdominal/abdominoperineal resection group, 15 in the sacrectomy group and 10 in the abdominosacral resection group. The operative data, postoperative data and prognosis were compared among the three groups. Survival curve was conducted using the Kaplan-Meier method, and log-rank test was used to compare survival difference among three groups.Results:There were no significant differences in baseline data among three groups (all P>0.05). All the 47 patients completed the radical resection successfully. The mean operation time was (4.7±2.1) hours, the median intraoperative blood loss was 600 ml, and the median postoperative hospitalization time was 17 days. Fifteen cases (31.9%) had perioperative complications, of which 3 cases were grade III-IV. There was no perioperative death. The mean operative time was (7.4±1.6) hours in the abdominosacral resection group, (4.9±1.6) hours in the abdominal/abdominoperineal resection group, and (3.0±1.1) hours in the sacroectomy group, with a significant difference ( F=25.071, P<0.001). There were no significant differences in intraoperative blood loss, postoperative hospitalization days and perioperative complications among the three groups (all P>0.05). The median follow-up period of all the patients was 24 months, 12 cases (25.5%) developed postoperative dysfunction. The incidence of postoperative dysfunction in the abdominosacral resection group was 5/10, which was higher than 4/15 in the sacrectomy group and 3/22 (13.6%) in the abdominoperineal resection group with statistically significant difference (χ 2=9.307, P=0.010). The 1-year and 3-year overall survival rates were 86.1% and 40.2% respectively. The 1-year overall survival rates were 86.0%, 86.7% and 83.3%, and the 3-year overall survival rates were 33.2%, 40.0% and 62.5% in the abdominal/abdominoperineal resection group, sacrectomy group and abdominosacral resection group, respectively, whose difference was not statistically significant (χ 2=0.222, P=0.895). Conclusions:Abdominal/abdominoperineal resection, sacrectomy and abdominosacral resection are all effective for PRRC. Intraoperative function protection should be concerned for patients undergoing abdominosacral resection.

[Comparative study of clinical efficacy between abdominoperineal resection and anterior resection procedure in patients with rectal cancer].

Comparison of Two Different Neoadjuvant Chemoradiatiotherapy Regimens for Locally Advanced Rectal Cancer: Results of a Phase II, Multicenter, Randomized Trial.

Clinical Evaluation of Laparoscopic Abdominoperineal Resection for Cancer of the Low Rectum

Comparison of outcomes of abdominoperineal resection vs low anterior resection in very-low rectal cancer

Neoadjuvant Radiotherapy Improves Overall Survival for T3/4N+M0 Rectal Cancer Patients: a Population-Based Study of 20300 Patients

[Meta-analysis comparing long-term outcomes of intersphincteric resection versus abdominoperineal resection for low rectal cancer]

Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis

Laparoscopic Vs Open Abdominoperineal Resection in the Multimodality Management of Low Rectal Cancers.

Comparison of Quality of Life in Patients Undergoing Abdominoperineal Extirpation or Anterior Resection for Rectal Cancer

Laparoscopic Extralevator Abdominoperineal Resection Versus Laparoscopic Abdominoperineal Resection for Lower Rectal Cancer: A Retrospective Comparative Study from China

Laparoscopic Versus Open Abdominoperineal Resection in the Treatment of Low Rectal Cancer：a Clinical Comparative Study

Comparison of Clinical Efficacy among Different Surgical Methods for Presacral Recurrent Rectal Cancer

Robot-assisted Vs Laparoscopic Vs Open Abdominoperineal Resections for Low Rectal Cancer: Short-term Outcomes of a Single-Center Prospective Randomized Controlled Trial

A comparative study of total endoscopic and laparoscopic assisted anterior resection for rectal cancer

Multicenter Study of Surgical and Oncologic Outcomes of Extra-Levator Versus Conventional Abdominoperineal Excision for Lower Rectal Cancer

[Extralevator Abdominoperineal Excision Versus Traditional Abdominoperineal Excision in the Treatment of Low Rectal Cancer].

Randomized Clinical Trial of Conventional Versus Cylindrical Abdominoperineal Resection for Locally Advanced Lower Rectal Cancer

Prospective controlled study of the safety and oncological outcomes of ELAPE procure with definitive anatomic landmarks versus conventional APE for lower rectal cancer.

Evaluation of Short-Term Outcomes of Laparoscopic and Open Total Mesorectal Excision for Mid and Distal Rectal Cancer

Abdominoperineal Excision Following Preoperative Radiotherapy for Rectal Cancer: Unfavorable Prognosis Even with Negative Circumferential Resection Margin.

Long-term Outcomes After Surgery Involving the Pelvic Floor in Rectal Cancer: Physical Activity, Quality of Life, and Health Status